Advanced in Wilson Disease

Chii-min S. Hwu

No. 201, Sec. 2, Shipai Road, 
Beitou, TPQ, TW 
Advanced in Wilson Disease
No. 201, Sec. 2, Shipai Road, 
Beitou, TPQ, TW 
OverviewLocationsClinical Research

Overview

Chii-min Hwu practices in Beitou, Taiwan. Hwu is rated as an Advanced expert by MediFind in the treatment of Wilson Disease. Their top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Cushing's syndrome due to Adrenal Tumor, Leg or Foot Amputation, and Thyroidectomy.

Their clinical research consists of co-authoring 180 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Wilson Disease.

Locations

No. 201, Sec. 2, Shipai Road, Beitou, TPQ 11217, Taiwan
Other Locations
No.201, Sec. 2, Shipai Road, Beitou, TPQ 11217, Taiwan
No. 155, Sec. 2, Li Nong Street, 112, Beitou, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3

180 Total Publications

SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study.
SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study.
Journal: Journal of the Royal Society of Medicine
Published: November 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hwu's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile